Oxygen Saturation Monitoring During Transport Between the Operating Room and the Post-anesthesia Care Unit (SpO2)

December 17, 2025 updated by: University Hospital, Strasbourg, France
To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the Post-Anesthesia Care Unit (PACU) reduces the incidence of desaturations

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service d'Anesthésie - CHU de Strasbourg - France
        • Contact:
        • Principal Investigator:
          • Vincent MATEO, MD
        • Principal Investigator:
          • Cécile LEPINE, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patient (≥ 18 years old) scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025

Description

Inclusion Criteria:

  • Adult patient (≥ 18 years old)
  • Patient scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025

Exclusion Criteria:

- Administration of premedication that may impair judgment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction of the incidence of desaturations
Time Frame: upon Arrival in the Recovery Room

To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the PACU reduces the incidence of desaturations by recording:

  • The last SpO₂ reading taken upon leaving the operating room
  • The first SpO₂ reading taken upon arrival in the recovery room
  • The lowest SpO₂ reading taken during the transfer between the operating room and the recovery room (for patients monitored by pulse oximetry)
upon Arrival in the Recovery Room

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2025

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

December 17, 2025

First Submitted That Met QC Criteria

December 17, 2025

First Posted (Estimated)

January 2, 2026

Study Record Updates

Last Update Posted (Estimated)

January 2, 2026

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 9538

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe